Atherosclerosis, Hypertension and Diabetes Book

	Dedication: A Tribute to Dr. Setsuro Ebashi
	Preface
	Acknowledgements
1	PPAR-Alpha in Lipid and Lipoprotein Metabolism, Vascular Inflammation and Atherosclerosis	3
2	The Choice of an Appropriate Animal Species in the Study of Chlamydia pneumoniae as an Atherogenic Agent	17
3	Endothelial Cell Dysfunction - A Key Factor in Atherogenesis and its Reversal (Laboratory and Clinical Study)	27
4	Biochemical Mechanisms of Hyperhomocysteinemia in Atherosclerosis: Role of Chemokine Expression	53
5	Oxyradicals and Hypercholesterolemic Atherosclerosis	63
6	Identification, Regulation and Function of LOX-1, A Novel Receptor for Ox-LDL	71
7	Atherosclerosis and Angiotensin II in Hypercholesterolemia and Diabetes. A Role for AT[subscript 1] Receptors Beyond Hypertension	83
8	Basic and Clinical Results of New Statin: Pitavastatin	99
9	Reducing Cardiovascular Risk With HMG CoA Reductase Inhibitors, Potential Contribution From Platelets	107
10	Rapamycin-Sensitive Signal Transduction Pathways and the Control of Adipogenesis	119
11	Genetic Predisposition to Hypertension and Cardiovascular Disease	131
12	Role of Sympathetic Nervous System in Hypertension	139
13	Role of Hypothalamic Peptides in the Development of Hypertension	155
14	Myosin Light Chain Kinase in Endothelial Cell Calcium Signaling and Endothelial Functions	163
15	Sarpogrelate Inhibits Genes Involved in Vascular Neointimal Hyperplasia and Remodeling	175
16	A Nutritional Approach to Prevent High Blood Pressure	187
17	Cardiovascular and Renal Actions of Leptin	197
18	Brain Na, K-ATPase Enzymatic Activity and Cardiovascular Regulation	211
19	Development of Transdermal and Transbuccal Drug Delivery Systems for Cardioactive Drugs with Special Reference to Anti-Hypertensive Agents	229
20	Insulin Resistance and Experimental Hypertension	247
21	New Paradigm for Insulin Resistance: The HISS Story	263
22	Vanadium Effects in Diabetes	277
23	Dyslipoproteinemia and Fibrinolysis	289
24	Endothelins and Cardiovascular Disease in Diabetes	301
25	Usefulness of 5-HT[subscript 2A] Receptor Antagonists for the Treatment of Cardiovascular Complications in Diabetes	317
26	Selective Attenuation of Enhanced Angiotensin II Mediated Responses in the Streptozotocin Diabetic Rat Thoracic Aorta by Tempol	327
27	Role of Renin-Angiotensin System in Diabetic Heart Dysfunction and Changes in Phospholipase C Activity	339
28	Regulation of Cardiac Function in Diabetes	353
29	Diabetes and Cardiac Dysfunction	373
30	Mechanisms Underlying Contractile Dysfunction in Streptozotocin-Induced Type 1 and Type 2 Diabetic Cardiomyopathy	387
31	Protein Kinase C Signaling and Expression of the Diabetic Cardiac Phenotype	409
32	Oxidative Stress in Cardiovascular Complications of Diabetes	427
33	Augmented Energy Transfer in Rat Heart Mitochondria: Compensatory Response to Abnormal Household of Energy in Acute Diabetes	439
34	Ketosis, Tumor Necrosis Factor-[alpha] and Cardiovascular Disease in Type-1 Diabetic Patients	455
35	Epigenetic Alterations in Diabetic Cardiomyopathy	465
	Index	481